AXONIS Therapeutics is a recent start-up structured around tackling breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders. Based in LabCentral, MA , the Axonis team is assembling a team to address adult-onset central nervous system (CNS) - disorders that - as peope are living longer - are an increasingly important need. With a focus on developing therapies in neurorestorative treatments for spinal cord injury and neuron degeneration and excitation/inhibition imbalances being an underlying problems of many debilitating neurological disorders,AXONIS is developing a pipeline of neuron-reviving therapeutics designed to enable an intrinsic ability of CNS neurons to: (1) resist neurodegeneration, (2) restore excitation/inhibition balance, and (3) regenerate.
